MetLife Inc
0K0X.L
$78.34 0.35%
Exchange: LSE | Sector: Financial Services | Industry: Insurance Diversified
Q3 2025
Published: Nov 7, 2025

Earnings Highlights

  • Revenue of $17.36B down 5.1% year-over-year
  • EPS of $1.22 decreased by 32.4% from previous year
  • Net income of 896.00M
  • "N/A" - N/A
0K0X.L
Company 0K0X.L

Executive Summary

MetLife’s QQ3 2025 quarter (ended 2025-09-30) delivered solid operating discipline against a backdrop of a modest top-line decline. Revenue reached $17.361 billion, up modestly versus the prior quarter (+1.08% QoQ) but down year over year (-5.12% YoY). Operating income was $1.481 billion, marking a double‑digit QoQ improvement (+51.12%) but a sharper YoY decline (βˆ’25.73%), with net income of $0.896 billion and GAAP diluted EPS of $1.22–$1.23. The quarterly margin profile remained constructive, with an operating margin of 8.53%, a pretax margin of 6.97%, and a net margin of 5.16%. The company’s balance sheet continues to reflect a conservative risk posture: a debt ratio of 2.81%, debt/equity of 0.699, and substantial liquidity evidenced by cash per share of $30.44 and a broad capital base represented by a price-to-book ratio near 1.89 and a payout ratio around 42%. Valuation remains reasonable within the global life-insurer space (P/E ~15.3; EV multiple ~37x). While YoY earnings drift highlights some earnings headwinds, the sequential improvement in operating income and disciplined capital management support a cautiously constructive near-term outlook, contingent on macro rates and investment performance.

Key Performance Indicators

Revenue
Decreasing
17.36B
QoQ: 1.08% | YoY: -5.12%
Operating Income
Decreasing
1.48B
QoQ: 51.12% | YoY: -25.73%
Net Income
Decreasing
896.00M
QoQ: 22.91% | YoY: -33.23%
EPS
Decreasing
1.23
QoQ: 18.27% | YoY: -32.42%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 17,361.00 1.22 -5.1% View
Q2 2025 17,176.00 1.03 -1.8% View
Q1 2025 18,263.00 1.28 +14.9% View
Q4 2024 18,440.00 1.78 -3.1% View
Q3 2024 18,298.00 1.81 +15.3% View